Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells

Front Pharmacol. 2022 Jan 28:13:842512. doi: 10.3389/fphar.2022.842512. eCollection 2022.

Fedor Simko^{1

2

3}, Tomas Baka¹

¹ Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
² 3rd Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
³ Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.

No abstract available

Keywords: ACE2; COVID-19; SARS-CoV-2; angiotensin 1–7; angiotensin II; captopril; losartan.